id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1981-N-0012-0052,FDA,FDA-1981-N-0012,FDA/OC to Wyeth Consumer Healthcare (Arnold & Porter LLP) - Letter,Other,Letter(s),2011-07-20T04:00:00Z,2011,7,2011-07-20T04:00:00Z,,2011-07-20T19:32:17Z,,0,0,0900006480ec707a
FDA-1981-N-0012-0050,FDA,FDA-1981-N-0012,"Reference 10 - LET84, 1981N-0022  [Notice of Proposed Rule Published 3/9/2011]",Supporting & Related Material,N-Notice (Supporting and Related Material),2011-03-11T05:00:00Z,2011,3,,,2011-03-11T15:52:26Z,,0,0,0900006480c05685
FDA-1981-N-0012-0045,FDA,FDA-1981-N-0012,List of References to the Proposed Rule of 3/9/2011,Supporting & Related Material,N-Notice (Supporting and Related Material),2011-03-10T05:00:00Z,2011,3,,,2011-03-10T21:05:42Z,,0,0,0900006480c05600
FDA-1981-N-0012-0047,FDA,FDA-1981-N-0012,"Reference 7 - LET82, 1981N-0022   [Notice of Proposed Rule Published 3/9/2011]",Supporting & Related Material,N-Notice (Supporting and Related Material),2011-03-10T05:00:00Z,2011,3,,,2011-03-10T22:12:03Z,,0,0,0900006480c05680
FDA-1981-N-0012-0046,FDA,FDA-1981-N-0012,"Reference 1 -  FDA, “Draft Guidance for Industry--Developing Products for Weight Management,” February 2007 [Notice of Proposed Rule Published 3/9/2011]",Supporting & Related Material,N-Notice (Supporting and Related Material),2011-03-10T05:00:00Z,2011,3,,,2011-03-10T21:07:15Z,,0,0,0900006480c05602
FDA-1981-N-0012-0048,FDA,FDA-1981-N-0012,"Reference 8 -  LET87, 1981N-0022  [Notice of Proposed Rule Published 3/9/2011]",Supporting & Related Material,N-Notice (Supporting and Related Material),2011-03-10T05:00:00Z,2011,3,,,2011-03-10T22:18:25Z,,0,0,0900006480c05681
FDA-1981-N-0012-0049,FDA,FDA-1981-N-0012,"Reference 13 - Summary Minutes of the 11th meeting of the Advisory Review Panel on OTC Miscellaneous  Internal Drug Products held on May 9-10, 1976, OTC Vol. 170010 [Notice of Proposed Rule Published 3/9/2011]",Supporting & Related Material,N-Notice (Supporting and Related Material),2011-03-10T05:00:00Z,2011,3,,,2011-03-10T22:54:20Z,,0,0,0900006480c056b2
FDA-1981-N-0012-0044,FDA,FDA-1981-N-0012,Weight Control Drug Products for Over-the-Counter Human Use: Benzocaine; Status Change,Proposed Rule,NPR-Notice of Proposed Rule-Making,2011-03-09T05:00:00Z,2011,3,2011-03-09T05:00:00Z,2011-06-08T03:59:59Z,2011-06-11T16:25:42Z,2011-05145,0,0,0900006480c03fb5
FDA-1981-N-0012-0043,FDA,FDA-1981-N-0012,"Thompson Medical Company, Inc. - Protocol Review",Other,PR-Protocol Review,2011-02-28T05:00:00Z,2011,2,2011-02-28T05:00:00Z,,2011-02-28T17:43:27Z,,0,0,09000064805ae84c
FDA-1981-N-0012-0040,FDA,FDA-1981-N-0012,"FDA/HFD-210 to Thompson Medical Company, Inc. - Letter",Other,LET-Letter,2011-02-28T05:00:00Z,2011,2,2011-02-28T05:00:00Z,,2011-02-28T17:35:08Z,,0,0,09000064805ae732
FDA-1981-N-0012-0033,FDA,FDA-1981-N-0012,"Tab B - Weight Control Drug Products For Over-The Counter Human Use; Certain Active Ingredients: Final Rule Federal Register Vol 56, No. 153. 21 CFR Part 310 - [Thompson Medical Company, Inc.- Citizen Petition]",Other,CP-Citizen Petition,2011-02-28T05:00:00Z,2011,2,2011-02-28T05:00:00Z,,2011-02-28T17:28:29Z,,0,0,09000064805ae82d
FDA-1981-N-0012-0041,FDA,FDA-1981-N-0012,"FDA/HFD-210 to Thompson Medical Company, Inc. - Letter",Other,LET-Letter,2011-02-28T05:00:00Z,2011,2,2011-02-28T05:00:00Z,,2011-02-28T17:38:23Z,,0,0,09000064805ae823
FDA-1981-N-0012-0031,FDA,FDA-1981-N-0012,FDA/CDER to Arnold & Porter,Other,LET-Letter,2006-10-03T04:00:00Z,2006,10,,,2008-05-30T22:52:38Z,,0,0,09000064805aea87
FDA-1981-N-0012-0030,FDA,FDA-1981-N-0012,HFA-305 to Wyeth,Other,ACK-Acknowledgement Letter,2006-03-30T05:00:00Z,2006,3,,,2008-05-30T22:52:55Z,,0,0,09000064805ae981
FDA-1981-N-0012-0029,FDA,FDA-1981-N-0012,FDA,Notice,NPR-Notice of Proposed Rule-Making,2006-01-25T05:00:00Z,2006,1,2005-12-21T05:00:00Z,2006-03-23T04:59:59Z,2008-05-30T22:52:38Z,,0,0,09000064805ae8fc
FDA-1981-N-0012-0026,FDA,FDA-1981-N-0012,Public Health Advisory; Safety of Phenylpropanolamine,Other,M-Memorandum,2004-09-17T04:00:00Z,2004,9,,,2008-05-30T22:53:23Z,,0,0,09000064805ae8e6
FDA-1981-N-0012-0025,FDA,FDA-1981-N-0012,HFN-810 to Nonprescription Drug Manufactures Assn.,Other,LET-Letter,2004-08-03T04:00:00Z,2004,8,,,2008-05-30T22:53:16Z,,0,0,09000064805ae8e5
FDA-1981-N-0012-0009,FDA,FDA-1981-N-0012,"HFA-305 to Thompson Medical Company, Inc.",Other,ACK-Acknowledgement Letter,2003-12-11T05:00:00Z,2003,12,,,2008-05-30T22:53:09Z,,0,0,09000064805ae8d3
FDA-1981-N-0012-0008,FDA,FDA-1981-N-0012,"Dr. DeLap, Ms. Walling/FDA and Dr. Walter Kerman/Yale U.",Other,MT-Memorandum of Telephone Conversation,2003-10-22T04:00:00Z,2003,10,,,2008-05-30T22:53:02Z,,0,0,09000064805ae8d2
FDA-1981-N-0012-0014,FDA,FDA-1981-N-0012,"HFA-305 to Caprice-Grestoke, Ltd.",Other,ACK-Acknowledgement Letter,1995-02-09T05:00:00Z,1995,2,,,2008-05-30T22:53:16Z,,0,0,09000064805ae8d9
FDA-1981-N-0012-0012,FDA,FDA-1981-N-0012,"HFA-305 to Caprice-Grestoke, Ltd",Other,ACK-Acknowledgement Letter,1995-02-02T05:00:00Z,1995,2,,,2008-05-30T22:53:23Z,,0,0,09000064805ae8d7
FDA-1981-N-0012-0013,FDA,FDA-1981-N-0012,"HFA-305 to Caprice-Grestoke, Ltd",Other,ACK-Acknowledgement Letter,1995-02-02T05:00:00Z,1995,2,,,2008-05-30T22:53:16Z,,0,0,09000064805ae8d8
FDA-1981-N-0012-0010,FDA,FDA-1981-N-0012,"HFA-305 to Caprice-Greystoke, Ltd",Other,ACK-Acknowledgement Letter,1994-12-14T05:00:00Z,1994,12,,,2008-05-30T22:53:23Z,,0,0,09000064805ae8d5
FDA-1981-N-0012-0011,FDA,FDA-1981-N-0012,"HFA-305 to Caprice-Greystoke, Ltd",Other,ACK-Acknowledgement Letter,1994-10-24T04:00:00Z,1994,10,,,2008-05-30T22:53:23Z,,0,0,09000064805ae8d6